Showing 14401 to 14415 of 23315 results
8th Edition R&D Controlling & Performance Management

8th Edition R&D Controlling & Performance Management

12 - 14 September, 2022

Berlin, Germany

The marcus evans 8th Edition R&D Controlling & Performance Management conference taking place on 12-14 September, 2022 in Berlin, Germany, will enable R&D Finance leaders from across industries to discuss how to focus resources and build performance management competencies that achieve a real business impact. The event will explore ways to measure performance, balance risk and rewards in the portfolio, create a company culture based in innovation...

  • +6 months
Seeking innovative solutions to Automation and optimization of stowage planning

Seeking innovative solutions to Automation and optimization of stowage planning

Game Changer Technologies and Ideas Qatar Research, Development and Innovation Council
Read moreContact
MIT Sloan ACE holder Hamilton Mann and global teams at Thales turn the pandemic business disruption into a boost for digital transformation

MIT Sloan ACE holder Hamilton Mann and global teams at Thales turn the pandemic business disruption into a boost for digital transformation

The MIT Sloan Advanced Certificate for Executives in Management, Innovation, and Technology (ACE) program tends to draw business leaders who appreciate in-depth, hands-on learning experiences because they see the value in applying what they learn immediately in their organizations. Hamilton Mann, Group Director, Global Digital Marketing and Digital Transformation at Thales Group is no exception. Thales Group is a global leader in advanced t...

Article

  • +3 months
Targeting Interleukin-6 Helps to Mitigate the Side Effects of Immunotherapy

Targeting Interleukin-6 Helps to Mitigate the Side Effects of Immunotherapy

Researchers at The University of Texas MD Anderson Cancer Center have identified a new strategy to reduce immune-related adverse events by targeting immunotherapy with the cytokine interleukin-6 (IL-6). The study, published in Cancer Cell, provides evidence for the concept of combining immune checkpoint blockers and cytokine blockers to selectively inhibit inflammatory autoimmune responses.   While immunotherapy in combination with anti-pd...

Article

  • +3 months
Small Molecules for Treatment of Huntington's Disease and Related Disorders

Small Molecules for Treatment of Huntington's Disease and Related Disorders

Patents for licensing Yeda
Read moreContact
Metallic Catalysts for the Preferential Activation of Ammonia Over Other

Metallic Catalysts for the Preferential Activation of Ammonia Over Other

Patents for licensing Consejo Superior de Investigaciones Científicas
Read moreContact